600521 Zhejiang Huahai Pharmaceutical

Huahai Pharmaceutical (600521): The advantages of API integration help high performance growth, outstanding R&D innovation highlights

05-03 00:00

Huahai Pharmaceutical (600521): The 2022 performance is in line with expectations, and the pharmaceutical business is developing rapidly

05-03 00:00

Huahai Pharmaceutical (600521): Dual wheel drive performance can be expected, increased innovation is expected to open up space

02-10 11:11

Huahai Pharmaceutical (600521): Signed a VV116 production agreement and operations continued to rise

02-01 13:26

Huahai Pharmaceutical (600521): Performance is in line with expectations and the inflection point of recovery throughout the year is clear

11-01-2022 00:00:00

Huahai Pharmaceutical (600521): Internationalization of advanced pharmaceutical manufacturing leaders opens up room for growth

10-10-2022 09:36:04

Huahai Pharmaceutical (600521): the company's performance enters the high growth channel and the growth momentum is expected to be further strengthened in the medium term.

08-31-2022 17:11:24

Huahai Pharmaceutical (600521) 2022 Annual report performance Forecast comments: the overall improvement of the three major business sectors led the company's quarterly and semi-annual performance to an all-time high

07-14-2022 10:21:32

Huahai Pharmaceutical Co., Ltd. (600521): Yueming Pharmaceutical Advanced Manufacturing Leader set sail again

05-22-2022 13:11:04

Huahai Pharmaceutical (600521): Growth momentum is still strong, equity incentives are inspiring

05-05-2021 00:00:00